BIVDA Press Releases

Sep 03, 2021
BIVDA has released a statement on the recent Blood Collection Tube shortages being faced by the medical sector and NHS. Please find the downloadable file below.
Read More
Jul 23, 2021
Please see the below quote from BIVDA regarding exemptions for key workers regarding COVID-19 app alerts:  "BIVDA welcomes flexibility for essential workers in exceptional circumstances and is looking forward to receiving further guidance from the Government on the process involved. Fast, decisive action is key in circumstances such as this and we support the action taken to prevent further issues. We know this may not have gone as far as many of our member companies would wi...
Read More
Jul 22, 2021
BIVDA Comments on new Innovation Strategy BIVDA Chief Executive Doris-Ann Williams has commented on the Government’s new Innovation Strategy, which aims to put Britain at the front of the global race to attract world-leading science expertise, highly skilled jobs and new products.According to the Government, the UK is committed to increasing annual public investment on R&D to £22 billion. The private sector also plays a key role in boosting spending on R&D, which is an e...
Read More
Jul 13, 2021
BIVDA has partnered with Zinc Media to produce a series of documentary-format programs, focusing on the in vitro diagnostics sector, and showcasing powerful examples of the value that IVD’s bring to healthcare.   The content series will look at IVD’s role in the current pandemic and how this manifests into preparedness for future pandemics, the importance of IVDs in tackling the antimicrobial resistance challenge, along with sustainability and how the industry plans to redu...
Read More
Jul 13, 2021
Professional Accredited Registration (‘Credentialing’) is supported by BIVDA, but the use of appointment systems increases risk and delay in services and incurs un-necessary cost for suppliers.  BIVDA (British In Vitro Diagnostics Association) is the national industry association for the manufacturers and distributors of in vitro (IVD) products in the UK, representing almost 200 organisations including multi-nationals and SME’s.  BIVDA members supply products, equipme...
Read More
Jul 12, 2021
BIVDA launches its Sustainability Training Programme for members in partnership with SGS.   Sustainability is a key issue of operational transformation that the in-vitro diagnostics (IVD) sector must take heed of in light of the NHS Net Zero requirements, corporate social responsibility (CSR) and the duty we share to conserve the environment. As the trade association for the IVD sector, BIVDA is pleased to be able to help empower and facilitate member companies on their journey towards...
Read More
Jun 28, 2021
Please see below a quote from Doris-Ann Williams, CEO of BIVDA, welcoming the new Secretary of State for Health and Social Care to his position. “On behalf of BIVDA, I am delighted to welcome Mr Javid to his new position of Secretary of State for Health.  We look forward to building on our strong working relationship with his Department as we emerge from the pandemic and aim to build a stronger diagnostic capacity in the NHS over the coming months. In-vitro diagnostics (IVDS) wil...
Read More
Jun 23, 2021
BIVDA Comments on new Government Clinical Research Implementation Plan BIVDA has commented on the new Government plan to boost clinical research – ‘The Future of UK Clinical Research Delivery.’ The strategy builds on existing commitments and is intended to bring research and greater investment to our shores, bolstering our economic growth, tackling health inequalities and improving the health of people right across the UK. The strategy contains five key themes:  ...
Read More
Jun 14, 2021
BIVDA has launched the latest in its series of strategic papers, ‘The Digital Revolution’.  BIVDA is publishing this paper to ensure that the digitisation of In vitro Diagnostics (IVD) and the breakthroughs, experiences and collaboration resultant from the coronavirus pandemic are not limited to being a short-term phenomenon. The last year has demonstrated that the IVD industry has the ability and capacity to transform healthcare through an early diagnosis culture which prevents...
Read More
Jun 08, 2021
BIVDA responds to G7 Communique on antimicrobial resistance (AMR) BIVDA has responded to the communique published by the attendees at the G7 meeting in Cornwall, pledging to do more to tackle the problem of AMR. Across the world, AMR is responsible for hundreds of thousands of avoidable deaths a year and the numbers are increasing year on year by 4% - and will continue to do so as current antibiotics lose their effectiveness against new and evolving strains of bacteria.  Commentin...
Read More
Page 1 of 12 FirstPrevious [1]